Evidence map›Paper›PMID 39305318›Full record

ArticleHeart and vessels2025

Comparative analysis of recurrence predictors and outcomes for atrial tachyarrhythmia following atrial fibrillation ablation: high-power short-duration vs. conventional pulmonary vein isolation.

Kyoichiro Yazaki, Koichiro Ejima, Shohei Kataoka, Satoshi Higuchi, Miwa Kanai, Daigo Yagishita, Morio Shoda, Junichi Yamaguchi

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kyoichiro YazakiDepartment of Cardiology, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan.ORCID http://orcid.org/0000-0001-8839-0186
Koichiro EjimaDepartment of Cardiology, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan. koichiro@qf6.so-net.ne.jp.
Shohei KataokaDepartment of Cardiology, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Satoshi HiguchiDepartment of Cardiology, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Miwa KanaiDepartment of Cardiology, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Daigo YagishitaDepartment of Cardiology, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Morio ShodaDepartment of Cardiology, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Junichi YamaguchiDepartment of Cardiology, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrial fibrillation (AF) is a common cardiac arrhythmia, with structural and electrical remodeling being significant risk factors for recurrence post-catheter ablation. The advent of high-power short-duration pulmonary vein isolation (HPSD-PVI) presents a novel approach, potentially enhancing procedural success rates through the creation of transmural lesions without overheating. This study investigates the predictors of atrial tachyarrhythmia (ATA) recurrence and compares outcomes between HPSD-PVI and conventional PVI techniques. A total of 1005 patients undergoing radiofrequency catheter ablation (RFA) for AF were retrospectively analyzed in this study. The cohort was divided based on the ablation strategy: conventional PVI from February 2013 to September 2018, and HPSD-PVI from October 2018 onwards. The primary objective was to compare the predictors of ATA recurrence and the outcome between the two groups. Among 969 patients analyzed after exclusions, independent predictors of recurrence differed between groups; higher CHADS

Indexed as

Atrial FibrillationCatheter AblationPulmonary VeinsAgedFemaleFollow-Up StudiesHeart RateHumansMaleMiddle AgedRecurrenceRetrospective StudiesRisk FactorsTime FactorsTreatment OutcomeAtrial fibrillationAtrial fibrillation ablationAtrial tachyarrhythmia recurrenceCHA2DS2-VASc scoreCHADS2 scoreHigh-power short-duration pulmonary vein isolation

Identifiers

PMID39305318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.